Company Overview of CalciMedica, Inc.
CalciMedica, Inc., a biotechnology company, engages in the discovery and development of novel small molecule drugs for the treatment of inflammatory and autoimmune disorders, and organ transplant rejection. Its drug discovery strategy is based on the specific inhibition of calcium release-activated calcium channels, a network for the activation of immune cells. The company primarily focuses on medications in immunosuppressant therapy. CalciMedica, Inc. was founded in 2006 and is based in La Jolla, California.
505 Coast Boulevard South
La Jolla, CA 92037
Founded in 2006
Key Executives for CalciMedica, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
To contact CalciMedica, Inc., please visit www.calcimedica.com. Company data is provided by Capital IQ. Please use this form to report any data issues.